Funded by the NIH HEAL Initiative℠
Black/African American persons in urban communities are experiencing the fastest increases and high rates of opioid overdose deaths and high disparities in engagement and retention in MOUD treatment. This multisite hybrid implementation-effectiveness clinical trial aims to evaluate the integration of MOUD with buprenorphine in trusted, non-medical community settings (including faith-based or secular community centers, churches, mosques, or family support centers) with Peer Recovery Specialists and recovery guide counseling to improve engagement and retention in MOUD treatment of Black persons with OUD. In addition, this study will evaluate implementation barriers and facilitators.
Principal Investigator(s)
Richard Schottenfeld, MD
2041 Georgia Avenue, NW
Washington, DC 20060
United States
Niranjan Karnik, M.D., Ph.D.
1747 West Roosevelt Road
Chicago, IL 60608
United States
José Szapocznik, Ph.D.
1425 N.W. 10th Avenue
Room 309
Miami, FL 33136
United States